Latest news, updates, and announcements from Korsana Biosciences.
Korsana Biosciences emerged with $175M to develop KRSA-028, a brain-penetrant Alzheimer's antibody using THETA technology that shuttles drugs across the blood-brain barrier via transferrin receptor ta...
